摘要
雄性激素和雄激素受体(AR)在前列腺癌的发展中起着至关重要的作用。雄激素阻断疗法(ADT)已经成为治疗转移性前列腺癌患者的主要方法。ADT能够降低血清睾酮水平,从正常范围500到600ng/dl之间到切除睾丸后的水平。手术切除睾丸后,大约四分之三的病人的血清睾酮水平降到不足20ng/dl(0.69nmol/L)。虽然在进行ADT后导致血清睾酮水平的抑制不足到目前为止仍未被充分认识到,但是在切除睾丸后的睾丸素水平降低的不成功对前列腺癌证幸存患者确实产生了副作用。尽管在去除睾丸后的循环的睾丸素水平不一定反映前列腺内睾丸素或者二氢睾酮,睾丸素的数量,ADT治疗主要源自于瘤内合成前体细胞和肾上腺雄激素。以分别针对肾上腺或者前列腺内雄性激素的生物合成的醋酸阿比特龙和针对增强AR信号的恩咋鲁胺为代表的新兴药物已经恢复了在ADT过程中的睾丸素水平的热度。我们用专门对雄性激素代谢和其在前列腺癌生物学和治疗方面的重大意义进行了综述,以促进对它们更好的了解及其在前列腺癌患者中更好的作用。
关键词: 雄性激素代谢,雄激素受体,雄激素阻断治疗,前列腺癌
图形摘要
Current Drug Targets
Title:Androgen Metabolic Pathway Involved in Current and Emerging Treatment for Men with Castration Resistant Prostate Cancer: Intraprostatic Androgens as Therapeutic Targets and Endocrinological Biomarkers
Volume: 15 Issue: 13
Author(s): Noboru Hara and Noboru Hara
Affiliation:
关键词: 雄性激素代谢,雄激素受体,雄激素阻断治疗,前列腺癌
摘要: Androgen and androgen receptor (AR) play a critical role in the development of prostate cancer. Androgen deprivation therapy (ADT) has become the therapeutic mainstay for patients with metastatic prostate cancer. ADT can reduce the serum testosterone level from the normal range between 500 and 600 ng/dl to the castrate level. Following surgical castration, the serum testosterone level decreases to less than 20 ng/dL (0.69 nmol/L) in about three quarters of the patients. Although insufficient suppressions of the serum testosterone level following ADT have not been well recognized to date, the failure in achieving the castrate level of testosterone may have an adverse impact on survival in men with prostate cancer. Although circulating testosterone levels following castration do not necessarily reflect the amount of intraprostatic testosterone or dihydrotestosterone, testosterone during ADT mainly derives from intratumorally synthesized precursors and adrenal androgens. The advent of new agents represented by abiraterone acetate and enzalutamide, which target adrenal or intraprostatic androgen biosynthesis and AR signaling, respectively, has retrieved interest in testosterone levels during ADT. We critically reviewed androgen metabolism and its significance in prostate cancer biology and treatment to promote their better understanding and management of men with prostate cancer.
Export Options
About this article
Cite this article as:
Noboru Hara and Hara Noboru, Androgen Metabolic Pathway Involved in Current and Emerging Treatment for Men with Castration Resistant Prostate Cancer: Intraprostatic Androgens as Therapeutic Targets and Endocrinological Biomarkers, Current Drug Targets 2014; 15 (13) . https://dx.doi.org/10.2174/1389450115666141024114736
DOI https://dx.doi.org/10.2174/1389450115666141024114736 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In vivo Monitoring of Oxygen Levels in Human Brain Tumor Between Fractionated Radiotherapy Using Oxygen-enhanced MR Imaging
Current Medical Imaging Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Glycosides from Medicinal Plants as Potential Anticancer Agents: Emerging Trends Towards Future Drugs
Current Medicinal Chemistry Computational Analysis of the Interaction between Ligand-Receptor Pairs
Current Pharmaceutical Design Diagnostic, Prognostic and Therapeutic Potential of Heat Shock Proteins in Schistosomiasis and Bladder Cancer: A Review
Letters in Drug Design & Discovery Cytotoxic Thiol Alkylators
Mini-Reviews in Medicinal Chemistry Antimutagenic, Antiproliferative and Antioxidant Properties of Sea Grape Leaf Extract Fractions (<i>Coccoloba uvifera</i> L.)
Anti-Cancer Agents in Medicinal Chemistry Melatonin and Aromatase in Breast Cancer
Clinical Cancer Drugs Substitution at Phenyl Rings of Chalcone and Schiff Base Moieties Accounts for their Antiproliferative Activity
Anti-Cancer Agents in Medicinal Chemistry Clomiphene Citrate, Metformin or Both for Ovulation Induction in Therapy Naïve Women with Polycystic Ovary Syndrome (PCOS)? A Descriptive Review
Current Drug Therapy Stereological Quantification of Blood and Lymph Microvessels in Prostate Cancer. Its Relevance for the Anti-angiogenetic Therapy
Current Cancer Therapy Reviews Antidepressant-Like Components of Hypericum perforatum Extracts: An Overview of Their Pharmacokinetics and Metabolism
Current Drug Metabolism Impact of Drug Metabolism/Pharmacokinetics and their Relevance Upon Taxus-based Drug Development
Current Drug Metabolism Editorial (Thematic Issue: Mitochondria and Subcellular Organelles as Treatment Targets Against Pathological Conditions)
Current Pharmaceutical Design Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
Current Cancer Drug Targets Association Between Vitamin D Serum Level and Depression
Current Psychopharmacology Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling
Combinatorial Chemistry & High Throughput Screening Micro Arrays and Biochips: Applications and Potential in Genomics and Proteomics
Current Genomics Selective Anti-proliferative Activity of Indole Alkaloids from Rhazya stricta Decne Leaves
Letters in Organic Chemistry Glyoxalase Pathway of Trypanosomatid Parasites: A Promising Chemotherapeutic Target
Current Drug Targets